
Post QALY: Scientific Approaches to Real World Formulary Decision Making
Author(s) -
Paul C Langley,
Stephen P. McKenna
Publication year - 2020
Publication title -
innovations in pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2155-0417
DOI - 10.24926/iip.v11i2.3375
Subject(s) - formulary , nice , value (mathematics) , actuarial science , medicine , business , operations research , family medicine , computer science , engineering , machine learning , programming language
The purpose of this anniversary supplement for Innovations in Pharmacy is to consider and / or propose modern, scientific methods for determining the evidence base for the fair pricing and accessibility of pharmaceutical products and medical devices. At present, such decisions are based on the construction of imaginary value assessment models that fail to meet the standards of normal science. Such a business model has been adopted by the Institute for Clinical and Economic Review (ICER) in the US, NICE in the UK and in a number of other countries.
Article Type: Call for Papers